| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:525179852:1597 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:525179852:1597?format=raw |
LEADER: 01597cam a2200373 a 4500
001 3966661
005 20221027011353.0
008 910821t19921992caua b 001 0 eng c
010 $a 91005085
020 $a0804716692 (cloth : alk. paper) :$c$30.00
035 $a(OCoLC)24376708
035 $a(OCoLC)ocm24376708
035 $9AGD7265HS
035 $a(NNC)3966661
035 $a3966661
040 $aDNLM/DLC$cDLC$dDLC$dNNC$dNNC-M
043 $ad------
050 00 $aHD9674.D44$bS54 1992
060 0 $aQV 736 S587b
082 00 $a338.4/76151/091724$220
100 1 $aSilverman, Milton,$d1910-1997.$0http://id.loc.gov/authorities/names/n79045213
245 10 $aBad medicine :$bthe prescription drug industry in the Third World /$cMilton Silverman, Mia Lydecker, Philip R. Lee.
260 $aStanford, Calif. :$bStanford University Press,$c[1992], ©1992.
300 $axvii, 358 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references (p. [319]-339) and index.
650 0 $aPharmaceutical industry$xCorrupt practices$zDeveloping countries.
650 0 $aPharmaceutical policy$zDeveloping countries.
650 2 $aDeveloping Countries.$0https://id.nlm.nih.gov/mesh/D003906
650 2 $aDrug Industry$xstandards.$0https://id.nlm.nih.gov/mesh/D004345Q000592
700 1 $aLydecker, Mia,$d1926-$0http://id.loc.gov/authorities/names/n82022564
700 1 $aLee, Philip R.$q(Philip Randolph),$d1924-$0http://id.loc.gov/authorities/names/n80062918
852 00 $boff,hsl$hHD9674.D44$iS54 1992